Niche Indexing Poliwogg specializes in disease-specific indexes tied to healthcare cost data, presenting a unique selling proposition for financial instruments linked to medical expenditure trends.

Targeted Investors The client base includes indices licensed for specialized ETFs and unit investment trusts, highlighting opportunities to engage asset managers and funds focused on biotechnology, healthcare innovation, and health economics.

Revenue Growth Current revenue is under a million with significant funding raised; potential cross-sell of licensing, data licenses, and custom index development to expand monetization with existing data assets.

Data Advantage Proprietary paid-claims data underpinning monthly disease-cost indexes offers a defensible data moat; sales plays can emphasize data quality, timeliness, and custom benchmark solutions.

Platform Expansion Tech stack and cloud-based infrastructure suggest scalability for additional index products or white-label offerings; sales can pursue partnerships with financial tech providers and exchanges.